Basic Information
Basic information for MIR646HG-215-15aa
Peptide Name MIR646HG-215-15aa
Genome Position chr20:60088640-60088684[+]
Species Human
Peptide Sequence MRWGGWKQKAFSTPA
Peptide Length 15
Unique No (MIR646HG-202-15aa,MIR646HG-206-15aa-1,MIR646HG-210-15aa,MIR646HG-213-15aa,MIR646HG-216-15aa,MIR646HG-218-15aa,MIR646HG-219-15aa,MIR646HG-222-15aa,MIR646HG-224-15aa,MIR646HG-226-15aa,MIR646HG-229-15aa,MIR646HG-230-15aa,MIR646HG-234-15aa,MIR646HG-236-15aa,MIR646HG-244-15aa,MIR646HG-247-15aa,MIR646HG-248-15aa,MIR646HG-253-15aa,MIR646HG-254-15aa,MIR646HG-257-15aa,MIR646HG-258-15aa-1,MIR646HG-259-15aa-1,MIR646HG-262-15aa,MIR646HG-263-15aa)
Grand Average of Hydropathicity -0.88
Relative Molecular Mass 2003.27
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000228340;MIR646HG
Transcript ID/Name ENST00000653739;MIR646HG-215
Transcript Length 1712
Coding Ability 0.3551
DNA Sequence Corresponding to Peptide ATGAGGTGGGGAGGTTGGAAACAAAAGGCCTTCTCCACCCCAGCT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :